The BD2K Centers are propelling the data sharing revolution forward at every level of research
Six startups jockey for a place at the table. Who will succeed?
A closer look at the curation of models discussed in The Physiome: A Mission Imperative
Modeling tumors' diversity
Incremental progress and measured successes
Decades of steady progress in pharmacogenetics have unearthed hundreds of associations between genes and drug response. But the field has to solve some theoretical and practical issues before it can deliver on the promise of personalized drug therapy.
Contests involving algorithms for protein structure prediction, natural language processing, and computer-aided disease detection are giving researchers a jolt of adrenalin and moving these fields forward
Moving from intuition to evidence-based intervention
They've gone from hype to backlash. Now it's time for reality: How microarrays are being used to benefit healthcare